Drug Development Technology - The leading site for news and procurement in the drug development industry

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

X

Advertise with us

Esperoct

Esperoct (turoctocog alfa pegol) for the Treatment of Haemophilia A

Esperoct® (turoctocog alfa pegol) is a recombinant factor indicated for the treatment of haemophilia A in adults and children.

Ruzurgi

Ruzurgi (amifampridine) for the treatment of LEMS

Skyrizi

Skyrizi (risankizumab-rzaa) for the Treatment of Plaque Psoriasis

Dovato®

Dovato (dolutegravir/lamivudine) for the Treatment of HIV Infection

Nerlynx (neratinib) for the Treatment of Breast Cancer

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Filter by:

Projects by Region: Europe

Lamzede (velmanase alfa) to Treat Alpha-Mannosidosis

Lamzede® (velmanase alfa) is one of the first enzyme replacement therapies indicated for the treatment...
Read More...